← Oncology Approval Tracker

FDA DECISION ·

Regorafenib (Stivarga reference)

regorafenib · Teva Pharmaceuticals USA

First generic approvalFirst genericColorectal cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic tablets; FDA highlights use in metastatic colorectal cancer after fluoropyrimidine, oxaliplatin and irinotecan chemotherapy, anti-VEGF treatment, and anti-EGFR therapy if RAS wild type.

LAMPGEN ANALYSIS

Why it matters

A first generic can widen sourcing options for oral regorafenib in previously treated colorectal cancer.

What research teams should watch

Track the dispensing product and preserve toxicity monitoring and adherence counseling when the supplier changes.

PRIMARY RECORDS

Sources